CDI Monthly Movement

RNS Number : 7875O
Kore Potash PLC
04 October 2019
 

 

 

4 October 2019

 

Kore Potash Plc

("Kore Potash" or the "Company")

CDI Monthly Movement

 

Kore Potash plc (ASX: KP2, AIM: KP2, JSE: KP2) (Company) advises the following movements in CDIs over its ordinary shares during September 2019:

 

Balance - 31 August 2019

212,477,709

Net Movement *

-

Balance - 30 September 2019

212,477,709

 

* Increase/(Decrease) in the number of CDIs quoted on ASX as a result of transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE, as required by the ASX to be reported on a minimum monthly basis.

 

A copy of the Appendix 3B lodged with the ASX reflecting the movement is attached below.

 

 

 

ENDS

For further information, please visit www.korepotash.com or contact:

 

 

Kore Potash

Brad Sampson - CEO

 

 

Tel: +27 11 469 9140

Tavistock Communications

Jos Simson

Edward Lee

 

 

Tel: +44 (0) 20 7920 3150

Canaccord Genuity - Nomad and Broker

James Asensio

Henry Fitzgerald-O'Connor

 

 

Tel: +44 (0) 20 7523 4600

Shore Capital - Joint Broker

Jerry Keen

Toby Gibbs

Mark Percy

 

Tel: +44 (0) 20 7407 4050

 

 

 

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96  Origin: Appendix 5  Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

Kore Potash plc (ASX: KP2)

 

ARBN

621 843 614

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

CHESS Depositary Interests corresponding to fully paid ordinary shares (CDIs)

 

 

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

CDIs:

 

As at 31 August 2019

212,477,709

Net transfers *

-

As at 30 September 2019

212,477,709

 

* Transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE

 

 

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Increase/(Decrease) in the number of CDIs quoted on ASX as a result of transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE, as required to be reported on a minimum monthly basis.

 

 

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·    the date from which they do

·    the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·    the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

 

 

5

Issue price or consideration

 

Nil

 

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

Notification to ASX of the movement of CDIs quoted on ASX and ordinary shares quoted on AIM and JSE.

 

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

 

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

N/A

 

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

N/A

 

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3?  Include the +issue date and both values.  Include the source of the VWAP calculation.

N/A

 

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

N/A

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12).  For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Movements during September 2019.

 

 

 

 

 

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

212,477,709

Chess Depository Interests at a ratio of 1 CDI representing 1 fully paid ordinary share as issued on the ASX (noting that an additional 1,297,176,234 ordinary shares are at 30 September 2019 quoted on either the AIM market of the London Stock Exchange or on the Johannesburg Stock Exchange).

 

         

 

 

 

Number

+Class

9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

50,000,000

 

 

2,255,000

 

 

5,881,250

 

 

660,000

 

 

1,405,000

 

 

3,747,005

 

 

11,734,853

 

 

13,144,659

 

 

4,062,500

 

 

4,000,000

 

 

26,900,000

Unlisted Options exercisable at AUD 0.30 each expiring 15 Nov 2019

 

Performance Rights expiring 6 December 2020 (Emp)

 

Performance Rights expiring 1 March 2021 (Dir)

 

Performance Rights vesting on 31 May 2019 (Dir)

 

Performance Shares vesting on 31 May 2019

 

Performance Shares under a Short Term Incentive Scheme Plan for 2017

 

Performance Shares under the Long Term Incentive Plan

 

Equity Warrants exercisable at A$0.30 each expiring 29 March 2021

 

Performance Rights expiring 22 May 2022 (Dir)

 

Unlisted Options exercisable at £0.11 each expiring on 27 June 2020

 

Unlisted Options exercisable at £0.022 each expiring on 19 July 2024

 

 

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

 

Part 2 ‑ Bonus issue or pro rata issue

 

11

Is security holder approval required?

N/A

 

 

 

12

Is the issue renounceable or non-renounceable?

N/A

 

 

 

13

Ratio in which the +securities will be offered

N/A

 

 

 

14

+Class of +securities to which the offer relates

N/A

 

 

 

15

+Record date to determine entitlements

N/A

 

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

 

 

17

Policy for deciding entitlements in relation to fractions

N/A

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

 

 

 

19

Closing date for receipt of acceptances or renunciations

N/A

 

 

 

20

Names of any underwriters

N/A

 

 

 

21

Amount of any underwriting fee or commission

N/A

 

 

 

22

Names of any brokers to the issue

N/A

 

 

 

23

Fee or commission payable to the broker to the issue

N/A

 

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

N/A

 

 

 

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

 

 

 

26

Date entitlement and acceptance form and will be sent to persons entitled

N/A

 

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

 

 

 

28

Date rights trading will begin (if applicable)

N/A

 

 

 

29

Date rights trading will end (if applicable)

N/A

 

 

 

30

How do security holders sell their entitlements in full through a broker?

N/A

 

 

 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

N/A

 

 

 

33

+Issue date

N/A

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

 

(a)

 

+Securities described in Part 1

 

 

 

 

(b)

 

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 

Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

 

 

35

 

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

 

36

 

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

 

37

 

A copy of any trust deed for the additional +securities

 

 

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

 

 

 

 

 

 

39

Class of +securities for which quotation is sought

 

 

 

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·    the date from which they do

·    the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·    the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

 

 

 

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

 

 

         

 

 

 

 

 

Quotation agreement

 

1              +Quotation of our additional +securities is in ASX's absolute discretion.  ASX may quote the +securities on any conditions it decides. 

 

2              We warrant the following to ASX.

 

·              The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·              There is no reason why those +securities should not be granted +quotation.

 

·            An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·           Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·             If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3              We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4             We give ASX the information and documents required by this form.  If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins.  We acknowledge that ASX is relying on the information and documents.  We warrant that they are (will be) true and complete.

 

 

[ signed electronically ]

Sign here:                  ............................................................Date: 4 October 2019

                                      Joint Company Secretary 

 

Print name:              Henko Vos

 

== == == == ==

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCQZLBBKBFFFBD

Companies

Kore Potash (KP2)
UK 100

Latest directors dealings